Scientific foundation and value chain linkage
The series of events signed in Singapore and Malaysia marks a step forward in international cooperation on stem cell technology, and at the same time demonstrates a strategy to build a regenerative medicine ecosystem according to a closed value chain. This model aims to connect from research, technology transfer to practical implementation, instead of detached development.
In that picture, Longevity Medical plays a connecting and coordinating role, bringing scientific achievements closer to Vietnamese and regional customers.
In Singapore, cooperation between Cellcare Holdings Pte. Ltd., Cellresearch Corporation Pte. Ltd. and Cellcare Laboratory Sdn. Bhd. is considered a fundamental step. The parties link between research, production and market expansion to create conditions for technology to be applied in practice.
The focus is stem cell technology from the umbilical cord membrane, the research direction is associated with Assoc. Prof. Dr. BS Phan Toan Thang. After more than two decades, the scientific foundation has been built from initial research to production standardization according to CGMP standards and the implementation of initial clinical studies.
This technology is currently not only limited to laboratories but has moved closer to applicability. This is a notable shift in the field of regenerative medicine.
Mr. Ivor J Lim - Founder and Medical Director of CellResearch Corporation - said: "We have built a solid scientific and clinical foundation for more than 22 years, with stem cell products manufactured according to CGMP standards. However, for these achievements to become reality, strategic partners who are capable of deploying and operating the system are needed. This is the core value of this cooperation.
This assessment shows the role of the ecosystem with the participation of both scientists and businesses in narrowing the gap from research to application.
Practical implementation and connecting role
In Malaysia, the cooperation between Longevity LifeCare and Longevity Medical focuses on the application deployment stage. The international standard regenerative medicine center model is put into operation with a synchronous service system, allowing customer monitoring throughout the treatment process before - during - after.
This approach reflects the trend of modern medicine: not only treatment but also towards comprehensive, personalized care and long-term monitoring data.
Malaysia was chosen thanks to a clearer legal framework for some applications, helping therapies to be implemented in a transparent and controlled environment.
In this ecosystem, Longevity Medical plays a bridge role, bringing technologies from international research platforms closer to Vietnamese customers. This unit not only provides services but also builds a consistent consulting and companion model, focusing on personalization, compliance with medical standards and long-term effective monitoring.
According to Assoc. Prof. Dr. Phan Toan Thang, the biggest challenge of stem cells is not in potential but in implementation: "When there is a connection between research, technology transfer and operating systems, we can form a complete value chain. This helps patients have the opportunity to access new methods in a transparent and closely monitored environment.
In the context of increasing healthcare and longevity needs, the regenerative medical ecosystem model is expected to contribute to improving service standards. Not only supporting treatment, this direction also aims to extend the "healthspan" - the number of years of healthy life - and improve the quality of life.
Two activities in Singapore and Malaysia show a systematic development strategy, with science as the foundation, value chain as the structure and people as the center.
